Bullish
Immunovant Inc stock (US45258Q1058): Is its autoimmune pipeline strong enough to unlock new upside?
Immunovant Inc, a clinical-stage biotech company focused on autoimmune diseases, is gaining attention for its lead candidate, batolimab, and its subcu...